Dr John J Kryston, DO | |
1 Hospital Dr, Lewisburg, PA 17837-9350 | |
(570) 522-2510 | |
(570) 522-2705 |
Full Name | Dr John J Kryston |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 1 Hospital Dr, Lewisburg, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902866098 | NPI | - | NPPES |
001089173 | Medicaid | PA | |
KR051133 | Other | PA | HIGHMARK BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | OS004708L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John J Kryston, DO 1 Hospital Dr Ste 306, Lewisburg, PA 17837-9350 Ph: (570) 522-4110 | Dr John J Kryston, DO 1 Hospital Dr, Lewisburg, PA 17837-9350 Ph: (570) 522-2510 |
News Archive
Veloxis Pharmaceuticals A/S today announced dosing of the first patient in the STRATO (Switching kidney TRAnsplant patients with Tremor to LCP-tacrO) Phase IIIb study of LCP-Tacro in kidney transplant recipients experiencing drug-induced tremors.
Highly educated individuals with mild cognitive impairment that later progressed to Alzheimer's disease cope better with the disease than individuals with a lower level of education in the same situation, according to research published in the June issue of The Journal of Nuclear Medicine.
The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since it is also crucial to the healthy functioning of many immune cells in the body, not just B cells gone bad.
Octapharma AG today announced the start of the first of a series of Phase III studies for its new 10% high purity intravenous immunoglobulin (IVIG). The study will investigate the efficacy and safety of this novel immunoglobulin in the treatment of primary immune deficiency and, together with results from additional upcoming studies, will support its regulatory filing in Europe and the US.
› Verified 3 days ago
Robert William Lamparter, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Lewisburg, PA 17837 Phone: 570-522-4110 Fax: 570-522-4120 | |
Maria Mabel Fasano, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Lewisburg, PA 17837 Phone: 570-522-4110 Fax: 570-768-3911 | |
Sonia Yvette Newton, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Lewisburg, PA 17837 Phone: 570-522-2510 Fax: 570-522-2705 | |
Jenny Lee Boyle, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Lewisburg, PA 17837 Phone: 570-522-2510 Fax: 570-768-3911 | |
Dr. Kimberly A Levin, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Lewisburg, PA 17837 Phone: 570-522-2510 Fax: 570-522-2705 | |
Mr. Stephen Wall, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Lewisburg, PA 17837 Phone: 570-522-2510 Fax: 570-768-3911 |